Dermatology · Nottingham, MD
NPI
1952355190
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
7642 Belair Rd
Nottingham, MD, 21236
Phone (410) 665-3093
Groups this clinician bills Medicare through
Medicare paid, 2024
$697K
7,272 services
Medicare patients, 2024
1,675
Average age 74
Drug cost, 2024
$2.0M
1,969 prescriptions
Company payments, 2025
$270K
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Oanh Lauring was code 99214 (office e&m - established), 985 times for 745 patients. In total Oanh Lauring billed 7,272 services in 105 codes, and Medicare paid $697K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-04-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 985 | 745 | $92.04 | $91K |
| 17003 Destruction Skin Lesion | Office | 603 | 159 | $5.15 | $3,105 |
| 99213 Office E&M - Established | Office | 564 | 498 | $63.18 | $36K |
| 17110 Destruction Skin Lesion | Office | 498 | 431 | $82.17 | $41K |
| 99203 Office E&M - New | Office | 427 | 426 | $77.37 | $33K |
| J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 358 | 226 | $307.40 | $110K |
| 96573 Skin | Office | 343 | 228 | $160.40 | $55K |
| 96372 Injection Administration | Office | 292 | 69 | $10.75 | $3,139 |
| 17000 Destruction Skin Lesion | Office | 287 | 257 | $38.70 | $11K |
| 11106 Skin Biopsy | Office | 216 | 201 | $110.57 | $24K |
| 17111 Destruction Skin Lesion | Office | 102 | 81 | $100.82 | $10K |
| 17262 Destruction Skin Lesion | Office | 93 | 78 | $125.51 | $12K |
| 11102 Skin Biopsy | Office | 76 | 74 | $63.94 | $4,860 |
| 17004 Destruction Skin Lesion | Office | 75 | 63 | $125.45 | $9,409 |
| 10040 Removal or Shaving of Skin Growth | Office | 69 | 66 | $90.05 | $6,213 |
By year: 2022 $407K for 5,462 services; 2023 $609K for 6,643 services; 2024 $697K for 7,272 services.
Medicare prescription drug claims, 2024
In 2024, the drug Oanh Lauring prescribed most often to Medicare patients was Doxycycline Hyclate, with 289 prescriptions and refills. In total Oanh Lauring wrote 1,969 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Doxycycline Hyclate Generic | 289 | 548 | 101 | $8,516 |
| Minoxidil Generic | 176 | 521 | 92 | $2,865 |
| Ketoconazole Generic | 166 | 181 | 111 | $3,572 |
| Betamethasone Dipropionate Generic | 143 | 145 | 101 | $4,902 |
| Clobetasol Propionate Generic | 94 | 98 | 55 | $5,883 |
| Mupirocin Generic | 87 | 89 | 57 | $564 |
| Doxycycline Ir-Dr Doxycycline Monohydrate | 75 | 103 | 16 | $55K |
| Fluocinonide Generic | 71 | 92 | 47 | $6,348 |
| Valacyclovir Valacyclovir Hcl | 57 | 81 | 39 | $1,588 |
| Azithromycin Generic | 51 | 51 | 47 | $208 |
| Halobetasol Propionate Generic | 48 | 50 | 34 | $1,914 |
| Triamcinolone Acetonide Generic | 44 | 56 | 33 | $747 |
| Dupixent Pen Dupilumab | 40 | 42 | 11 | $156K |
| Terbinafine Hcl Generic | 38 | 38 | 16 | $253 |
| Ivermectin Generic | 35 | 48 | 24 | $7,999 |
Brand drugs: 357 claims; generic drugs: 1,612 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Oanh Lauring $270K ($270K in general payments such as food, travel and fees) from 26 companies. The largest payer was Galderma Laboratories, L.P. with $86K.
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. GALD.SW | 87 | $86K |
| UCB, Inc. UCB.BR | 85 | $76K |
| Abbvie Inc. ABBV | 58 | $46K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $32K |
| E.R. Squibb & Sons, L.L.C. BMY | 27 | $17K |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 30 | $8,657 |
| LEO Pharma Inc. | 16 | $737 |
| Genzyme Corporation SNY | 15 | $555 |
| Regeneron Healthcare Solutions, Inc. REGN | 15 | $447 |
| Novartis Pharmaceuticals Corporation NVS | 19 | $379 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.